| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.043 | 0.8 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |